Add time:07/19/2019         Source:sciencedirect.com

Background and aimsCirculating soluble urokinase plasminogen activator receptor (suPAR) is a marker of immune activation associated with atherosclerosis. Whether suPAR levels are associated with prevalent peripheral arterial disease (PAD) and its adverse outcomes remains unknown and is the aim of the study.

We also recommend Trading Suppliers and Manufacturers of delta(2-89)-tissue plasminogen activator (cas 105913-11-9). Pls Click Website Link as below: cas 105913-11-9 suppliers